QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
OTCMKTS:BVNRY

Bavarian Nordic A/S Stock Forecast, Price & News

$16.76
+0.75 (+4.69%)
(As of 12/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$16.70
$17.09
50-Day Range
$14.99
$19.05
52-Week Range
$9.66
$19.25
Volume
1,300 shs
Average Volume
1,078 shs
Market Capitalization
$3.22 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.38
30 days | 90 days | 365 days | Advanced Chart
Receive BVNRY News and Ratings via Email

Sign-up to receive the latest news and ratings for Bavarian Nordic A/S and its competitors with MarketBeat's FREE daily newsletter.


Bavarian Nordic A/S logo

About Bavarian Nordic A/S

Bavarian Nordic A/S focuses on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. It specializes in cancer immunotherapy which includes cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian and prostate cancer. Its products include IMVAMUNE for Ebola, HPV, HBV, and HIV diseases. The company was founded in 1994 and is headquartered in Kvistgaard, Denmark.

Headlines

Bavarian Nordic A/S (OTCMKTS:BVNRY) Short Interest Update
November 21, 2021 |  americanbankingnews.com
Bavarian Nordic A/S ADR
August 25, 2021 |  barrons.com
See More Headlines

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:BVNRY
CIK
N/A
Employees
711
Year Founded
N/A

Sales & Book Value

Annual Sales
$283.79 million
Cash Flow
$0.58 per share
Book Value
$4.28 per share

Profitability

Net Income
$42.52 million
Pretax Margin
-34.88%

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$3.22 billion
Optionable
Not Optionable

Company Calendar

Today
12/01/2021
Fiscal Year End
12/31/2021

MarketRank

Overall MarketRank

1.06 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -












Bavarian Nordic A/S (OTCMKTS:BVNRY) Frequently Asked Questions

How has Bavarian Nordic A/S's stock price been impacted by COVID-19 (Coronavirus)?

Bavarian Nordic A/S's stock was trading at $9.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BVNRY shares have increased by 86.2% and is now trading at $16.7550.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Bavarian Nordic A/S?

Bavarian Nordic A/S saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 1,000 shares, an increase of 100.0% from the October 31st total of 500 shares. Based on an average trading volume of 400 shares, the days-to-cover ratio is presently 2.5 days.
View Bavarian Nordic A/S's Short Interest
.

Who are Bavarian Nordic A/S's key executives?

Bavarian Nordic A/S's management team includes the following people:
  • Paul Chaplin, President & Chief Executive Officer
  • Henrik Birk, Chief Operating Officer & Executive Vice President
  • Henrik Neilsen Juuel, Chief Financial Officer & Executive Vice President
  • Laurence de Moerlooze, Chief Medical Officer & Executive Vice President
  • Tommi Kainu, Chief Business Officer & Executive Vice President

What is Bavarian Nordic A/S's stock symbol?

Bavarian Nordic A/S trades on the OTCMKTS under the ticker symbol "BVNRY."

How do I buy shares of Bavarian Nordic A/S?

Shares of BVNRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bavarian Nordic A/S's stock price today?

One share of BVNRY stock can currently be purchased for approximately $16.76.

How much money does Bavarian Nordic A/S make?

Bavarian Nordic A/S has a market capitalization of $3.22 billion and generates $283.79 million in revenue each year. The company earns $42.52 million in net income (profit) each year or ($0.60) on an earnings per share basis.

How many employees does Bavarian Nordic A/S have?

Bavarian Nordic A/S employs 711 workers across the globe.

What is Bavarian Nordic A/S's official website?

The official website for Bavarian Nordic A/S is www.bavarian-nordic.com.

Where are Bavarian Nordic A/S's headquarters?

Bavarian Nordic A/S is headquartered at Hejreskovvej 10A, Kvistgaard G7, 3490.

How can I contact Bavarian Nordic A/S?

Bavarian Nordic A/S's mailing address is Hejreskovvej 10A, Kvistgaard G7, 3490. The company can be reached via phone at (453) 326-8383, via email at [email protected], or via fax at 45-3326-8380.


This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.